Figure 3.
Figure 3a. Mean change in BMD response in the denosumab group at 36 mo
*Within-group ANCOVA test for heterogeneity
Figure 3b. Mean change in BMD response in the placebo group
*Within-group ANCOVA test for heterogeneity
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.